131 related articles for article (PubMed ID: 29328425)
1. Bioinformatics analysis of the CDK2 functions in neuroblastoma.
Bo L; Wei B; Wang Z; Kong D; Gao Z; Miao Z
Mol Med Rep; 2018 Mar; 17(3):3951-3959. PubMed ID: 29328425
[TBL] [Abstract][Full Text] [Related]
2. Microarray expression analysis of MYCN-amplified neuroblastoma cells after inhibition of CDK2.
Song H; Wu F; Li S; Wang Z; Liu X; Cui Y; Lin C
Neoplasma; 2017; 64(3):351-357. PubMed ID: 28253714
[TBL] [Abstract][Full Text] [Related]
3. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
Tuo Y; An N; Zhang M
Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis to screen key genes implicated in the differentiation of induced pluripotent stem cells to hepatocytes.
Lin R; Wang Y; Ji K; Liu Z; Xiao S; Zhou D; Chen Q; Shi B
Mol Med Rep; 2018 Mar; 17(3):4351-4359. PubMed ID: 29328449
[TBL] [Abstract][Full Text] [Related]
5. Identification of key candidate genes involved in melanoma metastasis.
Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
7. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
[TBL] [Abstract][Full Text] [Related]
9. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.
Giono LE; Manfredi JJ
Mol Cell Biol; 2007 Jun; 27(11):4166-78. PubMed ID: 17371838
[TBL] [Abstract][Full Text] [Related]
10. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
[TBL] [Abstract][Full Text] [Related]
11. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
12. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
Wang J; Tian Y; Chen H; Li H; Zheng S
Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
[TBL] [Abstract][Full Text] [Related]
13. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis.
Kuang Z; Guo L; Li X
Mol Med Rep; 2017 Oct; 16(4):4685-4693. PubMed ID: 28791394
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis.
Ye Q; Lei L; Aili AX
Eur J Gynaecol Oncol; 2015; 36(3):283-9. PubMed ID: 26189254
[TBL] [Abstract][Full Text] [Related]
17. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
19. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
Kang J; Sergio CM; Sutherland RL; Musgrove EA
BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]